Autonomous AI Agents Can Outperform Physicians. That’s Not the Hard Part.
MIRA beat physicians on diagnostic accuracy. AMIE matched them across 100 cases. Now comes the real test: whether regulated...
MIRA beat physicians on diagnostic accuracy. AMIE matched them across 100 cases. Now comes the real test: whether regulated...
A Nature Medicine study finds GPT-5.2, Gemini 3.1 Pro, and Claude Opus 4.6 outperform FDA-cleared clinical AI tools on...
Eli Lilly invested in Abridge's AI recruitment tool — but the real question is whether sites can operationalize patient...
ASCO and Ryght AI are using algorithms to select CDK4/6 inhibitor trial sites. Here's what ops teams need to...
ASCO and Ryght AI are using machine learning to select breast cancer trial sites. Here's what that means for...
At the 2026 Veeva R&D and Quality Summit in Copenhagen, Veeva Systems announced three major AI capabilities: Vault AI,...
Phesi finds fewer than 1 in 3 trial protocols connect to real patient data — meaning flawed assumptions reach...
Phesi's 2026 analysis found fewer than 1 in 3 trial protocols are linked to patient data—meaning AI tools are...
SPARK agentic AI validated prognostic biomarkers across 5,400 patients and 18 cancer types—here's what that means for trial enrichment...
FDA's April 2026 real-time clinical trial push exposes a fatal flaw: when AI updates itself mid-study, your protocol is...